STRUCTURED DECISION-MAKING ALGORITHM FOR SELECTING IMAGING MODALITIES IN ONCOLOGY: COMPARATIVE EVALUATION OF MSCT, MRI, AND PET/CT

Guzal Bakirovna Mamedova; Fayzieva Nozima Avazbek qizi

Authors

Guzal Bakirovna Mamedova Author
Fayzieva Nozima Avazbek qizi Author

Abstract

This study focuses on the development and validation of a structured decision-making algorithm for selecting appropriate imaging modalities in oncological patients. The proposed approach integrates key diagnostic parameters, including sensitivity, specificity, and the clinical applicability of each method in tumor detection, staging, and treatment monitoring.

References

1. World Health Organization. (2020). WHO report on cancer: Setting priorities, investing wisely and providing care for all. Geneva: WHO.

2. National Comprehensive Cancer Network. (2024). Clinical Practice Guidelines in Oncology. Available at: NCCN.org.

3. European Society for Medical Oncology. (2022). ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of cancers.

4. American College of Radiology. (2023). ACR Appropriateness Criteria®. Reston, VA.

5. Society of Nuclear Medicine and Molecular Imaging. (2022). Procedure Standard for FDG PET/CT Imaging in Oncology.

6. Fletcher J.W., Djulbegovic B., Soares H.P. et al. (2008). Recommendations on the use of 18F-FDG PET in oncology. Journal of Nuclear Medicine, 49(3), 480–508.

7. Jadvar H. (2016). FDG PET in oncology: Basics and clinical applications. Journal of Nuclear Medicine, 57(Suppl 1), 144S–149S.